Literature DB >> 2000218

Tumorigenic transformation of spontaneously immortalized fibroblasts from patients with a familial cancer syndrome.

F Z Bischoff1, L C Strong, S O Yim, D R Pratt, M J Siciliano, B C Giovanella, M A Tainsky.   

Abstract

Immortal cell lines arose spontaneously during in vitro culture of initially normal fibroblasts, MDAH041 and MDAH087, from patients with Li-Fraumeni familial cancer syndrome. Fibroblasts from a control donor, MDAH170, maintained a normal morphology and senesced at 31 population doublings. The immortal fibroblasts have several properties of transformed cells. In addition to having acquired an altered morphology and chromosomal anomalies, MDAH041 and MDAH087 have escaped from senescence, growing beyond 300 and 100 population doublings (pd), respectively. As early as 50 pd, these cells can be transformed by an activated H-ras oncogene to form tumors in nude mice. However, MDAH041 immortal cells were resistant to tumorigenic transformation by transfection with the v-abl oncogene.

Entities:  

Mesh:

Year:  1991        PMID: 2000218

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  9 in total

Review 1.  Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53.

Authors:  Ruoji Zhou; An Xu; Julian Gingold; Louise C Strong; Ruiying Zhao; Dung-Fang Lee
Journal:  Trends Pharmacol Sci       Date:  2017-08-14       Impact factor: 14.819

Review 2.  Genomic instability due to germline p53 mutations drives preneoplastic progression toward cancer in human cells.

Authors:  M A Tainsky; F Z Bischoff; L C Strong
Journal:  Cancer Metastasis Rev       Date:  1995-03       Impact factor: 9.264

3.  CREG1 enhances p16(INK4a) -induced cellular senescence.

Authors:  Benchamart Moolmuang; Michael A Tainsky
Journal:  Cell Cycle       Date:  2011-02-01       Impact factor: 4.534

4.  Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations.

Authors:  P K Liu; E Kraus; T A Wu; L C Strong; M A Tainsky
Journal:  Oncogene       Date:  1996-06-06       Impact factor: 9.867

5.  Regulation of MCP-1 chemokine transcription by p53.

Authors:  Katrin Hacke; Bladimiro Rincon-Orozco; Gilles Buchwalter; Simone Y Siehler; Bohdan Wasylyk; Lisa Wiesmüller; Frank Rösl
Journal:  Mol Cancer       Date:  2010-04-20       Impact factor: 27.401

6.  Interferon regulatory factors IRF5 and IRF7 inhibit growth and induce senescence in immortal Li-Fraumeni fibroblasts.

Authors:  Qunfang Li; Lin Tang; Paul Christopher Roberts; Janice M Kraniak; Aviva Levine Fridman; Olga I Kulaeva; Omid S Tehrani; Michael A Tainsky
Journal:  Mol Cancer Res       Date:  2008-05       Impact factor: 5.852

Review 7.  Critical pathways in cellular senescence and immortalization revealed by gene expression profiling.

Authors:  A L Fridman; M A Tainsky
Journal:  Oncogene       Date:  2008-08-18       Impact factor: 9.867

8.  N-(phosphonacetyl)-L-aspartate induces TAp73-dependent apoptosis by modulating multiple Bcl-2 proteins: potential for cancer therapy.

Authors:  A R M Ruhul Amin; V S Thakur; K Gupta; M K Agarwal; D N Wald; D M Shin; M L Agarwal
Journal:  Oncogene       Date:  2012-03-19       Impact factor: 9.867

9.  Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines.

Authors:  J E Burns; M C Baird; L J Clark; P A Burns; K Edington; C Chapman; R Mitchell; G Robertson; D Soutar; E K Parkinson
Journal:  Br J Cancer       Date:  1993-06       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.